Komal Jhaveri, MD
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Komal Jhaveri, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:45 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04872608 · A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast CancerMemorial Sloan Kettering Cancer Center · withdrawn · Metastatic Breast Cancer, Unresectable Breast Cancer · principal investigator
- Ph1NCT04556773 · A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast CancerAstraZeneca · active not recruiting · Metastatic Breast Cancer · principal investigator
- Ph1/Ph2NCT03344536 · A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast CancerMemorial Sloan Kettering Cancer Center · completed · Breast Cancer · principal investigator
- Ph1NCT01393509 · The First-in-human Phase I Trial of PU-H71 in Patients With Advanced MalignanciesMemorial Sloan Kettering Cancer Center · completed · Metastatic Solid Tumor, Lymphoma, Myeloproliferative Neoplasms (MPN) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Cannot read properties of undefined (reading 'length')
Nothing is shown here until the source responds. Reload to try again.